I

InnoCare Pharma
9969

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
HK$21.55B
EV
HK$15.80B
Shares Outstanding
1.76B
Beta
1.03

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$9.68
P/E 2025E
-
P/Revenue 2025E
14.44x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About InnoCare Pharma Limited

gainify

I

InnoCare Pharma Limited

9969

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r)...

Sector

Healthcare

Industry

Biotechnology

CEO

Cui, Jisong

Employees

1,089

IPO Date

2020-03-23

Headquarters

Building 8, No. 8 Life Science Park Road, Zhongguancun Life Science Park, Changping District, Beijing 102206, China

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved